List of Excipients in API RIPRETINIB
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing RIPRETINIB
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Deciphera Pharmaceuticals LLC | QINLOCK | ripretinib | 73207-101 | CELLULOSE, MICROCRYSTALLINE | 2040-12-30 |
Deciphera Pharmaceuticals LLC | QINLOCK | ripretinib | 73207-101 | CROSPOVIDONE | 2040-12-30 |
Deciphera Pharmaceuticals LLC | QINLOCK | ripretinib | 73207-101 | HYPROMELLOSE ACETATE SUCCINATE 06081224 | 2040-12-30 |
Deciphera Pharmaceuticals LLC | QINLOCK | ripretinib | 73207-101 | LACTOSE MONOHYDRATE | 2040-12-30 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for RIPRETINIB
Excipient focus: CELLULOSE, MICROCRYSTALLINE
RIPRETINIB drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Deciphera Pharmaceuticals LLC | ripretinib | 73207-101 |
>Company | >Ingredient | >NDC |
RIPRETINIB drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
RIPRETINIB drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Deciphera Pharmaceuticals LLC | ripretinib | 73207-101 |
>Company | >Ingredient | >NDC |
RIPRETINIB drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 06081224
RIPRETINIB drug variants containing HYPROMELLOSE ACETATE SUCCINATE 06081224
Company | Ingredient | NDC |
---|---|---|
Deciphera Pharmaceuticals LLC | ripretinib | 73207-101 |
>Company | >Ingredient | >NDC |
RIPRETINIB drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 06081224
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
RIPRETINIB drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Deciphera Pharmaceuticals LLC | ripretinib | 73207-101 |
>Company | >Ingredient | >NDC |
RIPRETINIB drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
RIPRETINIB drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Deciphera Pharmaceuticals LLC | ripretinib | 73207-101 |
>Company | >Ingredient | >NDC |
RIPRETINIB drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
RIPRETINIB drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Deciphera Pharmaceuticals LLC | ripretinib | 73207-101 |
>Company | >Ingredient | >NDC |
RIPRETINIB drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.